Leukemia Research
Volume 26, Issue 10 , Pages 955-963 , October 2002

Comparative analysis of the in vitro proliferation and expansion of hematopoietic progenitors from patients with aplastic anemia and myelodysplasia

  • Guadalupe Martı́nez-Jaramillo

      Affiliations

    • Oncological Research Unit, Oncology Hospital, National Medical Center, IMSS, Avenue Cuauhtemoc 330, Col. Doctores, 06720 Mexico City DF, Mexico
    • ,
  • Eugenia Flores-Figueroa

      Affiliations

    • Oncological Research Unit, Oncology Hospital, National Medical Center, IMSS, Avenue Cuauhtemoc 330, Col. Doctores, 06720 Mexico City DF, Mexico
    • ,
  • Elizabeth Sánchez-Valle

      Affiliations

    • Hematology Department, “Bernardo Sepúlveda” Hospital, National Medical Center, IMSS, Avenue Cuauhtemoc 330, Col. Doctores, 06720 Mexico City DF, Mexico
    • ,
  • Guillermo Gutiérrez-Espı́ndola

      Affiliations

    • Hematology Department, “Bernardo Sepúlveda” Hospital, National Medical Center, IMSS, Avenue Cuauhtemoc 330, Col. Doctores, 06720 Mexico City DF, Mexico
    • ,
  • Enrique Gómez-Morales

      Affiliations

    • Hematology Department, “Bernardo Sepúlveda” Hospital, National Medical Center, IMSS, Avenue Cuauhtemoc 330, Col. Doctores, 06720 Mexico City DF, Mexico
    • ,
  • Juan José Montesinos

      Affiliations

    • Oncological Research Unit, Oncology Hospital, National Medical Center, IMSS, Avenue Cuauhtemoc 330, Col. Doctores, 06720 Mexico City DF, Mexico
    • ,
  • Patricia Flores-Guzmán

      Affiliations

    • Oncological Research Unit, Oncology Hospital, National Medical Center, IMSS, Avenue Cuauhtemoc 330, Col. Doctores, 06720 Mexico City DF, Mexico
    • ,
  • Antonieta Chávez-González

      Affiliations

    • Oncological Research Unit, Oncology Hospital, National Medical Center, IMSS, Avenue Cuauhtemoc 330, Col. Doctores, 06720 Mexico City DF, Mexico
    • ,
  • J.Antonio Alvarado-Moreno

      Affiliations

    • Oncological Research Unit, Oncology Hospital, National Medical Center, IMSS, Avenue Cuauhtemoc 330, Col. Doctores, 06720 Mexico City DF, Mexico
    • ,
  • Hector Mayani

      Affiliations

    • Oncological Research Unit, Oncology Hospital, National Medical Center, IMSS, Avenue Cuauhtemoc 330, Col. Doctores, 06720 Mexico City DF, Mexico
    • Corresponding Author InformationCorresponding author. Tel.: +52-5-627-6959; fax: +52-5-761-0952

Received 4 December 2001 ,Accepted 15 February 2002.

References 

  1. Camitta BM, Storb R, Thomas ED. Aplastic anemia. N. Engl. J. Med. 1982;306:645–652
  2. Jacobs A. Myelodysplastic syndromes: pathogenesis, functional abnormalities and clinical implications. J. Clin. Pathol. 1985;38:1201–1217
  3. Young NS. The problem of clonality in aplastic anemia: Dr. Dameshek’s riddle restated. Blood. 1992;79:1385–1392
  4. Tuzuner N, Cox C, Rowe JM, Watrons D, Bennett JM. Hypocellular myelodysplastic syndromes (MDS): new proposals. Br. J. Haematol. 1995;91:612–617
  5. Maciejewski J, Selleri C, Sato T, Anderson S, Young NS. A severe and consistent deficit in marrow and circulating primitive hematopoietic cells (long-term culture initiating cells) in acquired aplastic anemia. Blood. 1996;88:1983–1991
  6. Martı́nez-Jaramillo G, Sánchez-Valle E, Gómez-Morales E, Montesinos JJ, Valencia I, Pizzuto-Chavez J, et al. Sequential variations in the content of bone marrow colony-forming cells in individual patients with aplastic anemia before and after immunosuppressive therapy. Hematology. 2000;5:247–255
  7. Asano H, Hotta T, Ichihara M, Murate T, Kobayashi M, Saito H. Growth analysis of marrow CD34-positive hematopoietic progenitor cells in patients with myelodysplastic syndromes. Leukemia. 1994;8:833–838
  8. Sato T, Kim S, Selleri C, Young NS, Maciejewski J. Measurement of secondary colony formation after 5 weeks in long-term cultures in patients with myelodysplastic syndrome. Leukemia. 1998;12:1187–1194
  9. Coutinho LH, Geary CG, Chang J, Harrison C, Testa NG. Functional studies of bone marrow haemopoietic and stromal cells in the myelodysplastic syndrome (MDS). Br. J. Haematol. 1990;75:16–25
  10. Gómez-Morales E, Martı́nez-Jaramillo G, Sánchez-Valle E, Valencia-Plata I, Arana-Trejo RM, Castro MA, et al. Deficient proliferation of myeloid, erythroid, and multipotent progenitor cells in long-term marrow cultures from patients with aplastic anemia treated with immunosuppressive therapy. Am J. Hematol. 1998;59:149–155
  11. Flores-Figueroa E, Gutiérrez-Espı́ndola G, Guerrero-Rivera S, Pizzuto-Chávez J, Mayani H. Hematopoietic progenitor cells from patients with myelodysplastic syndromes: in vitro colony growth and long-term proliferation. Leuk. Res. 1999;23:385–394
  12. Maciejewski J, Anderson S, Katevas P, Young NS. Phenotypic and functional analysis of bone marrow progenitor cell compartment in bone marrow failure. Br. J. Haematol. 1994;87:227–234
  13. Sawada K. Proliferation and differentiation of myelodysplastic CD34+ cells. Leuk. Lymphoma. 1996;12:43–51
  14. Mayani H, Baines P, Bowen DT, Jacobs A. In vitro growth of myeloid and erythroid progenitor cells from myelodysplastic patients in response to recombinant human granulocyte-macrophage colony-stimulating factor. Leukemia. 1989;3:29–32
  15. Merchav S, Wagemarker G, Souza LM, Tatarsky I. Impaired response of myelodysplastic marrow progenitors to stimulation with recombinant haematopoietic growth factors. Leukemia. 1991;5:340–346
  16. Philpott NJ, Scopes J, Marsh JCW, Gordon-Smith EC, Gibson FM. Increased apoptosis in aplastic anemia bone marrow progenitor cells: possible pathophysiologic significance. Exp. Hematol. 1995;23:1642–1648
  17. Martı́nez-Jaramillo G, Flores-Figueroa E, Gómez-Morales E, Sánchez-Valle E, Mayani H. Tumor necrosis factor-α levels in long-term marrow cultures from patients with aplastic anemia: modulation by granulocyte-macrophage colony-stimulating factor. Am J. Hematol. 2001;68:144–148
  18. Kitagawa M, Saito I, Kuwata T, Yoshida S, Yamaguchi S, Takahashi M, et al. Overexpression of tumor necrosis factor (TNF)-α and interferon (IFN)-α by bone marrow cells from patients with myelodysplastic syndromes. Leukemia. 1997;11:2049–2054
  19. Parker JE, Mufti GJ, Rasool F, Mijovic A, Devereux S, Pagliuca A. The role of apoptosis, proliferation, and the Bcl-2-related proteins in the myelodysplastic syndromes and acute myeloid leukemia secondary to MDS. Blood. 2000;96:3932–3938
  20. International Agranulocytosis and Aplastic Anemia Study. Incidence of aplastic anemia: the relevance of diagnosis criteria, Blood 70:1987;1718–22.
  21. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, et al. Proposals for the classification of the myelodysplastic syndromes. Br. J. Haematol. 1982;51:189
  22. Flores-Guzmán P, Gutiérrez-Rodrı́guez M, Mayani H, In vitro proliferation, expansion and differentiation of a CD34+ cell-enriched hematopoietic cell population from human umbilical cord blood in response to recombinant cytokines. Arch Med Res 2002;33:107–114.
  23. Koury MJ. Programmed cell death (apoptosis) in hematopoiesis. Exp. Hematol. 1992;20:391–394
  24. Mayani H, In vitro biology of the hematopoietic system in myelodysplastic syndromes. In: Raza A, Mundle SD, editors. Myelodysplastic syndromes and secondary acute myelogenous leukemia: directions for the new millennium, 1st ed. Boston: Kluwer Academic Publishers, 2001. p. 25–43.
  25. Sawada K, Sato N, Notoya A, Tarumi T, Hirayama S, Takano H, et al. Proliferation and differentiation of myelodysplastic CD34+ cells: phenotypic subpopulations of marrow CD34+ cells. Blood. 1995;85:194–202
  26. Nilsson L, Astrand-Grundstrom I, Arvidsson I, Jacobsson B, Hellstrom-Lindberg E, Hast R, et al. Isolation and characterization of hematopoietic progenitor/stem cells in 5q-deleted myelodysplastic syndromes: evidence for involvement at the hematopoietic stem cell level. Blood. 2000;96:2012–2021
  27. Bincoletto C, Saad ST, Soares da Silva E, Queiroz ML. Autonomous proliferation and bcl-2 expression involving haematopoietic cells in patients with myelodysplastic syndrome. Br. J. Cancer. 1998;78:621–624
  28. Gibson FM, Scopes J, Daly S, Ball SE, Gordon-Smith EC. In vitro response of normal and aplastic anemia bone marrow to mast cell growth factor and in combination with granulocyte-macrophage colony-stimulating factor and interleukin-3. Exp. Hematol. 1994;22:302–312
  29. Martı́nez-Jaramillo G, Gómez-Morales E, Mayani H. Effect of recombinant human granulocyte-macrophage colony-stimulating factor in long-term marrow cultures from patients with aplastic anemia. Am J. Hematol. 1999;61:107–114
  30. Wodnar-Filipowicz A, Chklovskaia E, Manz CY, Syman SD, Nissen C. Effect of Flt3 ligand on in vitro growth and expansion of colony-forming bone marrow cells from patients with aplastic anemia. Exp. Hematol. 1997;25:573–581
  31. Sawada K. Impaired proliferation and differentiation of myelodysplastic CD34+ cells. Leuk Lymphoma. 1994;14:37–47
  32. Piacibello W, Sanavio F, Bresso P, Severino A, Carlesso N, Pregno P, et al. Stem cell factor improvement of proliferation and maintenance of hemopoietic progenitors in myelodysplastic syndromes. Leukemia. 1994;8:250–257
  33. Ferrajoli A, Talpaz M, Kurzrock R, Harris D, Van Q, Estey EH, et al. Thrombopoietin stimulates myelodysplastic syndrome granulocyte-macrophage and erythroid progenitor proliferation. Leuk. Lymphoma. 1998;30:279–292
  34. Soligo DA, Campiglio S, Servida F, Bossolasco P, Romitti L, Cortelezzi A, et al. Response of myelodysplastic syndrome marrow progenitor cells to stimulation with cytokine combinations in a stroma-free long-term culture system. Br. J. Haematol. 1996;92:548–558
  35. Sawada K, Sato N, Notoya A, Tarumi T, Yasukouchi T, Yamaguchi M, et al. Proliferation. Eur. J. Haematol. 1995;54:85–94
  36. Yoshida Y. Apoptosis may be the mechanism responsible for the premature intramedullary cell death in myelodysplastic syndromes. Leukemia. 1993;7:144–149
  37. Raza A, Alvi S, Borok RZ. Excessive proliferation matched by excessive apoptosis in myelodysplastic syndromes: the cause–effect relationship. Leuk. Lymphoma. 1997;27:111–118
  38. Parker J, Mufti GJ, Rasool F, Mijovic A, Devereux S, Pagliuca A. The role of apoptosis, proliferation and the Bcl-2-related proteins in the myelodysplastic syndromes and acute myeloid leukemia secondary to MDS. Blood. 2000;96:3932–3938
  39. Raza A, Gregory SA, Preisler HD. The myelodysplastic syndromes in 1996: complex stem cell disorders confounded by dual actions of cytokines. Leuk. Res. 1996;20:881–890
  40. Span LFR, de Witte TM, Biology of stem and myeloid progenitor cells in myelodysplastic syndromes. In: Raza A, Mundle SD, editors. Myelodysplastic syndromes and secondary acute myelogenous leukemia: directions for the new millennium, 1st ed. Boston: Kluwer Academic Publishers, 2001. p. 45–63

PII: S0145-2126(02)00042-5

Leukemia Research
Volume 26, Issue 10 , Pages 955-963 , October 2002

Article Tools

* Image Usage & Resolution